Satranidazole
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101682This classification denotes an antiprotozoal agent with the molecular formula C8H11N5O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4N7G8A6439, chemically known as 2-imidazolidinone, 1-(1-methyl-5-nitro-1h-imidazol-2-yl)-3-(methylsulfonyl)- but generally known as satranidazole, which bears US NIH Compound Identifier 41841. European Medicines Agency schedules Satranidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10459MIG. The term SATRANIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). SATRANIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule satranidazole under HS 29350090 and SITC 51580. As of Q4 2014, SATRANIDAZOLE remains the US FDA Preferred Term for this commodity. Satranidazole bears US NLM identifiers UMLS ID C0141597 and NCI Concept Code C72155. SMILES: S(=O)(=O)(N1CCN(C1=O)C1N(C([N](=O)O)CN1)C)C.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.